Co-trimoxazole in urinary tract infection.
D058186:Acute Kidney Injury / Q000139:chemically induced; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001437:Bacteriuria / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008709:Methenamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D011776:Pyuria / Q000517:prevention & control; D012008:Recurrence; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000517:prevention & control*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D008709:Methenamine; D013420:Sulfamethoxazole